Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes

Diabetes Obes Metab. 2024 Dec 27. doi: 10.1111/dom.16169. Online ahead of print.

Authors

Cong Xie^{1

2}, Peter Iroga¹, Michelle J Bound¹, Jacqueline Grivell¹, Weikun Huang¹, Karen L Jones^{1

2}, Michael Horowitz^{1

2}, Christopher K Rayner^{1

3}, Tongzhi Wu^{1

2}

Affiliations

¹ Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, South Australia, Australia.
² Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
³ Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

PMID: 39727162
DOI: 10.1111/dom.16169

No abstract available

Keywords: antidiabetic drug; clinical trial; lactate; metformin; randomised trial; type 2 diabetes.

Publication types

Letter